View More View Less
  • 1 Országos Onkológiai Intézet, Budapest, Ráth György u. 7–9., 1122
  • | 2 Országos Onkológiai Intézet, Budapest
  • | 3 Semmelweis Egyetem, Általános Orvostudományi Kar, Budapest
Open access

Absztrakt:

Bevezetés és célkitűzés: Második emlőmegtartó műtét és nagy dózisteljesítményű szövetközi sugárkezelés eredményeinek bemutatása azonos oldali emlődaganat kiújulása miatt kezelt betegeknél. Módszer: Korai invazív emlőrák előzetes emlőmegtartó kezelése után jelentkező helyi daganatkiújulás miatt 1999 és 2015 között 33 betegnél végeztünk második emlőmegtartó műtétet perioperatív szövetközi sugárkezeléssel. A második emlőmegtartó műtét során a tumorágyba átlagosan 8 (tartomány: 4–24) darab flexibilis katétert ültettünk be. A perioperatív időszakban a tumorágy és annak 1–2 cm-es biztonsági zónájának területére adott összdózis 22 Gy volt (5 × 4,4 Gy, 3 nap alatt). Adjuváns szisztémás kezelésként 24 beteg (73%) egyedüli endokrin kezelésben, 6 beteg (18%) pedig kemoterápiában részesült. A túlélési eredményeket a Kaplan–Meier-módszerrel elemeztük. A késői mellékhatásokat és a kozmetikai eredményeket feljegyeztük. Eredmények: A második emlőmegtartó kezeléstől számított követési idő középértéke 61 hónap (tartomány: 26–189 hónap) volt. A követési idő alatt 4 betegnél (12,1%) alakult ki második lokális recidíva. A második helyi daganatkiújulás, a regionális daganatkiújulás és a távoli áttétképződés ötéves valószínűsége 6,3%, 6,1% és 14,9% volt, azonos sorrendben. Az ötéves betegségmentes, daganatspecifikus és teljes túlélés 76,2%, 92,4% és 89,2% volt. Kiváló, jó, megfelelő és rossz kozmetikai eredményt 4 (12%), 19 (58%), 4 (12%) és 6 (18%) betegnél állapítottunk meg. Grade 2-es és 3-as fibrosis 9 (27%) és 1 (3%) betegnél alakult ki. Tünetmentes zsírnekrózist 7 (21%) betegnél figyeltünk meg. Következtetés: A második emlőmegtartó műtét perioperatív szövetközi sugárkezeléssel biztonságos lehetőség az emlődaganat helyi kiújulásának kezelésére. A szövetközi sugárkezelés elfogadható kozmetikai eredmények és kevés késői mellékhatás mellett csökkentheti a második lokális kiújulás valószínűségét, így válogatott esetekben a standard mastectomiát helyettesítheti. Orv Hetil. 2018; 159(11): 430–438.

  • 1

    Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359–E386.

  • 2

    Kásler M, Ottó S, Kenessey I. The current situation of cancer morbidity and mortality in the light of the National Cancer Registry. [A rákmorbiditás és -mortalitás jelenlegi helyzete a Nemzeti Rákregiszter tükrében.] Orv Hetil. 2017; 158: 84–89. [Hungarian]

  • 3

    Kásler M, Polgár C, Fodor J. Current status of treatment for early-stage invasive breast cancer. [A korai emlőrák kezelésének aktuális helyzete.] Orv Hetil. 2009; 150: 1013–1021. [Hungarian]

  • 4

    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233–1241.

  • 5

    Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227–1232.

  • 6

    Darby S, McGale P, Correa C. 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378: 1707–1716.

  • 7

    Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys. 1989; 17: 719–725.

  • 8

    Salvadori B, Marubini E, Miceli R, et al. Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg. 1999; 86: 84–87.

  • 9

    Fodor J, Major T, Polgár C, et al. Prognosis of patients with local recurrence after mastectomy or conservative surgery for early-stage invasive breast cancer. Breast 2008; 17: 302–308.

  • 10

    Dalberg K, Mattsson A, Sandelin K, et al. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat. 1998; 49: 69–78.

  • 11

    Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer 1999; 85: 437–446.

  • 12

    Alpert TE, Kuerer HM, Arthur DW, et al. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys. 2005; 63: 845–851.

  • 13

    Komoike Y, Motomura K, Inaji H, et al. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Oncology 2003; 64: 1–6.

  • 14

    Abner AL, Recht A, Eberlein T, et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993; 11: 44–48.

  • 15

    van der Sangen MJ, van de Poll-Franse LV, Roumen RM, et al. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol. 2006; 32: 34–38.

  • 16

    Kurtz JM, Spitalier JM, Amalric R, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1990; 18: 87–93.

  • 17

    Doyle T, Schultz DJ, Peters C, et al. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys. 2001; 51: 74–80.

  • 18

    Beard HR, Cantrell EF, Russell GB, et al. Outcome after mastectomy for ipsilateral breast tumor recurrence after breast conserving surgery. Am Surg. 2010; 76: 829–834.

  • 19

    Botteri E, Rotmensz N, Sangalli C, et al. Unavoidable mastectomy for ipsilateral breast tumour recurrence after conservative surgery: patient outcome. Ann Oncol. 2009; 20: 1008–1012.

  • 20

    Lindford AJ, Meretoja TJ, von Smitten KA, et al. Skin-sparing mastectomy and immediate breast reconstruction in the management of locally recurrent breast cancer. Ann Surg Oncol. 2010; 17: 1669–1674.

  • 21

    Tanabe M, Iwase T, Okumura Y, et al. Local recurrence risk after previous salvage mastectomy. Eur J Surg Oncol. 2016; 42: 980–985.

  • 22

    Recht A, Schnitt SJ, Connolly JL, et al. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys. 1989; 16: 3–9.

  • 23

    Osborne MP, Simmons RM. Salvage surgery for recurrence after breast conservation. World J Surg. 1994; 18: 93–97.

  • 24

    Kurtz JM, Amalric R, Brandone H, et al. Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer 1988; 61: 1969–1672.

  • 25

    Kurtz JM, Jacquemier J, Amalric R, et al. Is breast conservation after local recurrence feasible? Eur J Cancer 1991; 27: 240–244.

  • 26

    Gentilini O, Botteri E, Veronesi P, et al. Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates. Ann Surg Oncol. 2012; 19: 3771–3776.

  • 27

    Ishitobi M, Komoike Y, Nakahara S, et al. Repeat lumpectomy for ipsilateral breast tumor recurrence after breast-conserving treatment. Oncology 2011; 81: 381–386.

  • 28

    Strnad V, Ott OJ, Hildebrandt G, et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. Lancet 2016; 387: 229–238.

  • 29

    Polgár C, Fodor J, Major T, et al. Breast-conserving therapy with partial or whole breast irradiation: Ten-year results of the Budapest randomized trial. Radiother Oncol. 2013; 108: 197–202.

  • 30

    Polgár C, Ott OJ, Hildebrandt G, et al. Late side-effects and cosmetic results of accelerated partial breast irradiation using interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2017; 18: 259–268.

  • 31

    Harris J, Levine M, Svensson G, et al. Analysis of cosmetic results following primary radiation therapy for stage I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys. 1979; 5: 257–261.

  • 32

    Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 1341–1346.

  • 33

    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457–481.

  • 34

    Deutsch M. Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys. 2002; 53: 687–691.

  • 35

    Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial breast irradiation as second conservative treatment for local breast cancer recurrence. Int J Radiat Oncol Biol Phys. 2004; 60: 1385–1392.

  • 36

    Hannoun-Levi JM, Resch A, Gal J, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group. Radiother Oncol. 2013; 108: 226–231.

  • 37

    Guix B, Lejárcegui JA, Tello JI, et al. Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study. Int J Radiat Oncol Biol Phys. 2010; 78: 804–810.

  • 38

    Trombetta M, Hall M, Julian TB. Long-term followup of breast preservation by re-excision and balloon brachytherapy after ipsilateral breast tumor recurrence. Brachytherapy 2014; 13: 488–492.

  • 39

    Chadha M, Feldman S, Boolbol S, et al. The feasibility of a second lumpectomy and breast brachytherapy for localized cancer in a breast previously treated with lumpectomy and radiation therapy for breast cancer. Brachytherapy 2008; 7: 22–28.

  • 40

    Maulard C, Housset M, Brunel P, et al. Use of perioperative or split-course interstitial brachytherapy for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am J Clin Oncol. 1995; 18: 348–352.

  • 41

    Resch A, Fellner C, Mock U, et al. Locally recurrent breast cancer: pulsed dose rate brachytherapy for repeat irradiation following lumpectomy – a second chance to preserve the breast. Radiology 2002; 225: 713–718.

  • 42

    Kauer-Dorner D, Pötter R, Resch A, et al. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol. 2012; 102: 96–101.

  • 43

    Trombetta M, Julian TB, Werts DE, et al. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast. Am J Clin Oncol. 2009; 32: 314–318.

  • 44

    Houvenaeghel G, Boher JM, Michel V, et al. Survival after breast cancer local recurrence according to therapeutic strategies. Eur J Surg Oncol. 2017; 43: 1409–1414.

  • 45

    Polgár Cs, Sulyok Z, Major T, et al. Reexcision and perioperative brachytherapy in the treatment of local relapse after breast conservation: a possible alternative to mastectomy. [Reexcízió és perioperatív brachyterápia az emlőmegtartó műtét utáni lokális recidíva kezelésére: a mastectomia lehetséges alternatívája.] Magy Seb. 2000; 53: 120–123. [Hungarian]

  • 46

    Polgár Cs, Sulyok Z, Major T, et al. Reexcision and perioperative high-dose-rate brachytherapy in the treatment of local relapse after breast conservation: an alternative to salvage mastectomy. J Contemp Brachytherapy 2009; 1: 131–136.

  • 47

    Harms W, Budach W, Dunst J, et al. DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Strahlenther Onkol. 2016; 192: 199–208.

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 139 102 6
PDF Downloads 203 173 14